Skip to main content

Table 3 Hospital treatment

From: Medical care of acute myocardial infarction patients in a resource limiting country, Trinidad: a cross-sectional retrospective study

Indicator

EBG Treatment (commencement)

ED treatment, % use in study

In-patient treatment, % use in study

Drugs

Dose (commencement)

 

Aspirin

300 mg then 81 mg daily (Day 1)

97.2

963(87.1)

Clopidogrel

300 mg then 75 mg daily (Day 1)

97.2

964(87.2)

Enoxaparin (Heparin)

1 mg/kg twice daily (Day 1)

81.3

80.6

ACE inhibitor/ARB

Initiate with low dose and titrate upwards (Day 1)

NA

806(72.9)

Beta blocker

Initiate with low dose and titrate upwards (Day 1)

30.3

846(76.5)

Statin

Night time max tolerated dose (Day 1)

NA

913(82.5)

Primary PCI

Not applicable (not a PCI center)

NA

NA

Nitrates

As required

15.0

809(73.1)

Investigations

 ECG

Daily (Day 1) at least 2

100.0

NA

 Cardiac enzymes

Daily (Day 1) at least 2

67.3

1106(100)

 Echocardiogram

Prior to discharge

NA

632(57.1)

 EST

If necessary

NA

NA

Risk stratification

 TIMI or GRACE score or other

Within 24 h

NA

NA

Surgical intervention

 Early invasive NSTEMI

Intermediate- and high-risk patient: 24 to 48 h of admission

Nil

Nil

 Late invasive NSTEMI

Low-risk patient: 25 to 72 h of admission

Nil

Nil

Lifestyle counseling

 Diet

Hospital stay

Nil

4.8

 Smoking

Hospital stay

Nil

1.9

 Exercise

Hospital stay

Nil

1.3

 Daily activity

Hospital stay

Nil

0.0–0.6

Cardiac rehab initiated

Hospital stay

Nil

0.0

Discharge medication

Pharmacist review day 4 and before discharge

Nil

Nil

  1. ACE angiotensin-converting enzyme, ARB angiotensin II receptor blocker, ECG electrocardiogram, EST exercise stress test, GRACE Global Registry of Acute Coronary Events, HR heart rate, NSTEMI non-ST-elevation myocardial infarction, PCI percutaneous coronary intervention, STEMI ST-elevation myocardial infarction, TIMI Thrombolysis in Myocardial Infarction, NA Treatment not available or missing data